Literature DB >> 10748027

The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats.

K M Howard1, M S Olson.   

Abstract

The production of platelet-activating factor (PAF) and PAF-like phospholipids that also bind the PAF receptor are implicated in numerous pathological situations including bacterial endotoxemia and injury-induced oxidative damage. PAF and PAF-like phospholipids are hydrolyzed and inactivated by the enzyme PAF acetylhydrolase. In the intact rat, infusion of lipopolysaccharide (LPS) into a mesenteric vein served as an acute, liver-focused model of endotoxemia. We determined that the liver responds to LPS exposure with the production of plasma-type PAF acetylhydrolase mRNA and protein expression specifically in the resident macrophages of the liver. Liver macrophages, defined immunohistochemically using antibodies against ED1, present in livers from saline-treated animals contained no detectable PAF acetylhydrolase. Twenty-four hours following in vivo LPS administration, immunohistochemistry detected a slight increase in the number of ED1 staining cells and the ED1-positive cells now contained an abundance of PAF acetylhydrolase. The systemic administration of LPS resulted in increased expression of PAF acetylhydrolase in several tissues. Of the tissues examined, the greatest increase in PAF acetylhydrolase expression was observed in lung followed by increases in spleen, liver, kidney, and thymus. Additionally, the expression of PAF acetylhydrolase mRNA increased in circulating leukocytes and in peritoneal macrophages in response to systemic exposure to LPS. We examined the regulation of PAF acetylhydrolase expression and demonstrated the administration of the PAF receptor antagonists, BN 50739 and WEB 2170, inhibited by 50% the increase in PAF acetylhydrolase expression in response to LPS. The up-regulation of the plasma-type PAF acetylhydrolase expression constitutes an important mechanism for elevating the local and systemic ability to inactivate PAF and oxidized phospholipids in order to minimize PAF-mediated pathophysiology consequent from exposure to endotoxin. The abundance of PAF acetylhydrolase production in the liver lobule likely limits endotoxin-mediated tissue damage due to PAF synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748027     DOI: 10.1074/jbc.M001462200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Platelet-activating factor in liver injury: a relational scope.

Authors:  Nikolaos-P Karidis; Gregory Kouraklis; Stamatios-E Theocharis
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 2.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

3.  Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

Authors:  Irene F Gazi; Fotini A Apostolou; Evangelos N Liberopoulos; Theodosios D Filippatos; Constantinos C Tellis; Moses S Elisaf; Alexandros D Tselepis
Journal:  Lipids       Date:  2011-06-19       Impact factor: 1.880

4.  New members of the mammalian glycerophosphodiester phosphodiesterase family: GDE4 and GDE7 produce lysophosphatidic acid by lysophospholipase D activity.

Authors:  Noriyasu Ohshima; Takahiro Kudo; Yosuke Yamashita; Stefania Mariggiò; Mari Araki; Ayako Honda; Tomomi Nagano; Chiaki Isaji; Norihisa Kato; Daniela Corda; Takashi Izumi; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2014-12-20       Impact factor: 5.157

5.  Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury.

Authors:  Rebecca C Garland; Dawei Sun; Souska Zandi; Fang Xie; Sepideh Faez; Faryan Tayyari; Sonja A F Frimmel; Alexander Schering; Shintaro Nakao; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2011-01-21       Impact factor: 5.191

6.  Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.

Authors:  Katherine M Howard; Mohammed Abdel-Al; Marcia Ditmyer; Nipa Patel
Journal:  Inflamm Res       Date:  2011-03-24       Impact factor: 4.575

7.  The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.

Authors:  Constantinos C Tellis; Eliza Moutzouri; Moses Elisaf; Robert L Wolfert; Alexandros D Tselepis
Journal:  J Lipid Res       Date:  2013-10-03       Impact factor: 5.922

8.  Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.

Authors:  Katherine M Howard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

9.  Decrease of plasma platelet-activating factor acetylhydrolase activity in lipopolysaccharide induced mongolian gerbil sepsis model.

Authors:  Junwei Yang; Jing Xu; Xiaoying Chen; Yixuan Zhang; Xucheng Jiang; Xiaokui Guo; Guoping Zhao
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

10.  Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.

Authors:  F Apostolou; I F Gazi; A Kostoula; C C Tellis; A D Tselepis; M Elisaf; E N Liberopoulos
Journal:  J Lipid Res       Date:  2009-06-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.